Last checked at 23 Oct 2009 07:20
Lupus Capital plc
("Lupus" or the "Company")
Shareholder undertakings
On 13 October 2009, the Company announced that it had received undertakings (which are either irrevocable or on a best endeavours basis) to vote against all of the resolutions at a general meeting of the Company to be held on 30 October 2009 (the "General Meeting") from institutional shareholders representing (in aggregate) 50,826,945 shares as at the date of that announcement.
The Company confirms that these undertakings now represent in aggregate 52,976,945 shares as at the date of this announcement, which equates to 40.8 per cent. of the Company's issued share capital as at the date of this announcement (excluding shares held by the Company in treasury).
23 October 2009
Enquiries:
| College Hill | Tel: +44 (0)20 7457 2020 |
| Mark Garraway / Gareth David | |
| Collins Stewart Europe Limited | Tel: +44 (0)20 7523 8350 |
| Mark Dickenson / Tom Hulme |
Collins Stewart Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as nominated adviser to Lupus Capital plc and is acting for no-one else in connection with the matters described in this announcement and will not be responsible to anyone other than Lupus Capital plc for providing the protections afforded to clients of Collins Stewart Europe Limited nor for providing advice in connection with the General Meeting or any other matter referred to herein.